Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Ikuto Sugita"'
Autor:
Yoshihiro Noguchi, Hayato Katsuno, Anri Ueno, Manami Otsubo, Aki Yoshida, Yuta Kanematsu, Ikuto Sugita, Hiroki Esaki, Tomoya Tachi, Teruo Tsuchiya, Hitomi Teramachi
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 4, Iss 1, Pp 1-8 (2018)
Abstract Background Incretin-based drugs are important in the treatment of type 2 diabetes. However, among the incretin-based drugs, glucagon-like peptide-1 receptor agonists (GLP-1-RAs) have been reported to cause gastroesophageal reflux disease (GE
Externí odkaz:
https://doaj.org/article/5d608066a8ab424f94ea2ae4f18df0c1
Autor:
Yoshihiro Noguchi, Anri Ueno, Hayato Katsuno, Manami Otsubo, Aki Yoshida, Yuta Kanematsu, Ikuto Sugita, Tomoya Tachi, Teruo Tsuchiya, Hitomi Teramachi
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 4, Iss 1, Pp 1-7 (2018)
Abstract Background The contents of the guidelines for the use of non-benzodiazepines (Z-drugs) differ slightly between THE JAPANESE SOCIETY OF SLEEP RESEARCH and THE JAPAN GERIATRIC SOCIETY, and the recommended directions are conflicting. Therefore,
Externí odkaz:
https://doaj.org/article/098c3ac2aa214524ba97bbde7f445e30
Autor:
Yoshihiro Noguchi, Anri Ueno, Manami Otsubo, Hayato Katsuno, Ikuto Sugita, Yuta Kanematsu, Aki Yoshida, Hiroki Esaki, Tomoya Tachi, Hitomi Teramachi
Publikováno v:
BMC Bioinformatics, Vol 19, Iss 1, Pp 1-7 (2018)
Abstract Background Patient background (e.g. age, sex, and primary disease) is an important factor to consider when monitoring adverse drug events (ADEs) for the purpose of pharmacovigilance. However, in disproportionality methods, when additional fa
Externí odkaz:
https://doaj.org/article/17029db0859b4bfda098e6b32f16110a
The adoption of generic drugs by a hospital: effects on drug dispensation among community pharmacies
Autor:
Tomoya Tachi, Kosuke Saito, Hiroki Esaki, Ikuto Sugita, Aki Yoshida, Yuta Kanematsu, Yoshihiro Noguchi, Michi Umeda, Masahiro Yasuda, Takashi Mizui, Teruo Tsuchiya, Chitoshi Goto, Hitomi Teramachi
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 4, Iss 1, Pp 1-8 (2018)
Abstract Background The objective of the current study is to elucidate the effect that the adoption of generic drugs by a large hospital has on the dispensation of generic drugs by community pharmacies. We evaluated the percentage of generic drugs di
Externí odkaz:
https://doaj.org/article/ecfd08bb6c2445b592c24733e569cdb5
Autor:
Hiroyuki Nagasawa, Ikuto Sugita, Tomoya Tachi, Hiroki Esaki, Aki Yoshida, Yuta Kanematsu, Yoshihiro Noguchi, Yukio Kobayashi, Etsuko Ichikawa, Teruo Tsuchiya, Hitomi Teramachi
Publikováno v:
Frontiers in Pharmacology, Vol 9 (2018)
Patients on dialysis require caregiving and assistance in their daily lives from family members and/or others for hospital visitation and supervised administration. This places a considerable burden on caregivers, which can in turn influence caregive
Externí odkaz:
https://doaj.org/article/2d695e04833e437ba49a38cfa42a6493
Autor:
Hiroyuki Nagasawa, Tomoya Tachi, Ikuto Sugita, Hiroki Esaki, Aki Yoshida, Yuta Kanematsu, Yoshihiro Noguchi, Yukio Kobayashi, Etsuko Ichikawa, Teruo Tsuchiya, Hitomi Teramachi
Publikováno v:
Frontiers in Pharmacology, Vol 9 (2018)
Dialysis treatment is known to lead to reduced quality of life (QOL) among patients. This decreased QOL is believed to influence medication compliance, although this effect has not yet been clarified. In this study, we investigated whether decreased
Externí odkaz:
https://doaj.org/article/2cfc6f170aba49659631811bbe5c3f71
Autor:
Yoshihiro Noguchi, Anri Ueno, Manami Otsubo, Hayato Katsuno, Ikuto Sugita, Yuta Kanematsu, Aki Yoshida, Hiroki Esaki, Tomoya Tachi, Hitomi Teramachi
Publikováno v:
Frontiers in Pharmacology, Vol 9 (2018)
Background: Adverse events (AEs) can be caused not only by one drug but also by the interaction between two or more drugs. Therefore, clarifying whether an AE is due to a specific suspect drug or drug-drug interaction (DDI) is useful information for
Externí odkaz:
https://doaj.org/article/3ad1ed43b2c04814a1e1f76d3d1b7f4c
Renoprotective Effect of Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus
Autor:
Hiroki Esaki, Tomoya Tachi, Chitoshi Goto, Ikuto Sugita, Yuta Kanematsu, Aki Yoshida, Kosuke Saito, Yoshihiro Noguchi, Yuki Ohno, Satoshi Aoyama, Masahiro Yasuda, Takashi Mizui, Masumi Yamamura, Hitomi Teramachi
Publikováno v:
Frontiers in Pharmacology, Vol 8 (2017)
Diabetic nephropathy is one of three major complications of diabetes mellitus, often leading to chronic renal failure requiring dialysis. Recently developed dipeptidyl peptidase-4 (DPP-4) inhibitors may exhibit renoprotective effects in addition to a
Externí odkaz:
https://doaj.org/article/4fd7079970134d78b5c4d268d6a421e4
Autor:
Yuta Kanematsu, Tomoya Tachi, Hitomi Teramachi, Hayato Katsuno, Yoshihiro Noguchi, Teruo Tsuchiya, Anri Ueno, Ikuto Sugita, Manami Otsubo, Hiroki Esaki, Aki Yoshida
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 4, Iss 1, Pp 1-8 (2018)
Journal of Pharmaceutical Health Care and Sciences
Journal of Pharmaceutical Health Care and Sciences
Background Incretin-based drugs are important in the treatment of type 2 diabetes. However, among the incretin-based drugs, glucagon-like peptide-1 receptor agonists (GLP-1-RAs) have been reported to cause gastroesophageal reflux disease (GERD)-like
Autor:
Aki Yoshida, Hayato Katsuno, Tomoya Tachi, Manami Otsubo, Teruo Tsuchiya, Hitomi Teramachi, Yoshihiro Noguchi, Ikuto Sugita, Yuta Kanematsu, Anri Ueno
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 4, Iss 1, Pp 1-7 (2018)
Journal of Pharmaceutical Health Care and Sciences
Journal of Pharmaceutical Health Care and Sciences
Background The contents of the guidelines for the use of non-benzodiazepines (Z-drugs) differ slightly between THE JAPANESE SOCIETY OF SLEEP RESEARCH and THE JAPAN GERIATRIC SOCIETY, and the recommended directions are conflicting. Therefore, we analy